GFM
EW icon

GF Fund Management’s Edwards Lifesciences EW Stock Holding History

GF Fund Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
16,089
+170
+1% +$14.2K 0.02% 169
2026
Q1 		$1.27M Hold
15,919
– – 0.02% 181
2025
Q4 		$1.36M Sell
15,919
-299
-2% -$24.5K 0.02% 184
2025
Q3 		$1.26M Buy
16,218
+2,735
+20% +$214K 0.02% 187
2025
Q2 		$1.05M Sell
13,483
-100
-0.7% -$7.46K 0.02% 208
2025
Q1 		$984K Hold
13,583
– – 0.02% 203
2024
Q4 		$1.01M Buy
+13,583
New +$951K 0.02% 200

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GF Fund Management's EW Position: Q2 2026 in Review

GF Fund Management increased its Edwards Lifesciences (EW) stake by 1.1% in Q2 2026, buying an estimated $14.2K and bringing the position to 16,089 shares worth $1.46M. The position accounts for 0.02% of the portfolio, ranked #169.

GF Fund Management first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • GF Fund Management held 16,089 shares of Edwards Lifesciences worth $1.46M as of Q2 2026.
  • GF Fund Management bought 170 Edwards Lifesciences shares in Q2 2026, an estimated $14.2K.
  • Edwards Lifesciences made up 0.02% of GF Fund Management's portfolio in Q2 2026, its #169 holding.
  • GF Fund Management first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.